Patent Law. Aegis shall promptly supply Lightlake with a copy of the disclosure for Lightlake evaluation purposes. Lightlake shall have the sole right to determine what, if any, patent applications should be filed.
Patent Law. Lightlake shall promptly supply Aegis with a copy of the disclosure for Aegis’ evaluation purposes. Aegis shall have the right to determine what, if any, patent applications should be filed. Aegis also retains full ownership of the Technology as defined above and sole licensing rights.
Patent Law. The Visiting Scientist agrees to permit the UNIVERSITY to review any data, results, manuscripts, or other information pertaining to the Program prior to any publication thereof, and to delay said publication for up to three (3) months if required for preparation of patent applications. Visiting Scientist further agrees to either acknowledge or refrain from identifying UNIVERSITY in any such publication, as requested in writing. Further, if UNIVERSITY objects to the inclusion in any such publication of any proprietary information, such proprietary information shall be excluded from such publication by Visiting Scientist. RUTGERS makes no warranties, express or implied, as to any matter whatsoever, including, without limitation, the availability or condition of the university research laboratories or collaborative research or any invention(s) or product(s), whether tangible or intangible, conceived, discovered, or developed under this agreement by university and used by visiting scientist; or the ownership, merchantability, or fitness for a particular purpose of the university research or any resulting invention or product. RUTGERS shall not be liable for any direct, indirect, consequential, or other damages suffered by any visiting scientist or licensee or any others resulting from the use of any RUTGERS facilities, equipment or research results or any such invention or product. RUTGERS makes no representation or warranty regarding actual or potential infringement of patents or copyrights of third parties, and visiting scientist acknowledges that the avoidance of such infringement in the design, use and sale of products and processes related to this research project shall remain the responsibility of visiting scientist. The obligations of the parties under paragraphs 5 through 11, inclusive, shall survive termination of this AGREEMENT. This AGREEMENT may be terminated by either the UNIVERSITY or the Visiting Scientist by providing thirty (30) days written notice by certified mail to the other party. Upon termination, Visiting Scientist agrees to submit to RUTGERS the original copy of the Research Notebook and any other written documentation pertinent to the Visiting Scientist's research performed under this AGREEMENT. This AGREEMENT constitutes the entire agreement and understanding between the UNIVERSITY and the Visiting Scientist and supersedes and cancels any and all prior oral or written understanding and agreement. No modifications, amendments, or waiv...
Patent Law. The rights of the Parties and of the Agency to Subject Inventions shall be as set forth in 37 CFR 401.14 (“Patent rights clause”). A Subject Invention shall be owned by the Party whose Personnel make or generate the Subject Invention and that Party may, at its discretion, perfect legal protection therein in its own name and at its own expense. All rights to Subject Inventions made solely by UNIVERSITY Personnel will belong solely to UNIVERSITY (“UNIVERSITY Inventions”). All rights to Subject Inventions made solely by SBC Personnel will belong solely to SBC (“SBC Inventions”). All rights to Subject Inventions made jointly by UNIVERSITY and SBC will belong jointly to UNIVERSITY and SBC unless otherwise agreed in writing by the Parties (“Joint Inventions”).
Patent Law. The National People's Congress adopted the Patent Law of the People's Republic of China in 1984, and amended it in 1992, 2000 and 2008. A patentable invention, utility model or design must meet three conditions: novelty, inventiveness and practical applicability. Patents cannot be granted for scientific discoveries, rules and methods for intellectual activities, methods used to diagnose or treat diseases, animal and plant breeds or substances obtained by means of nuclear transformation. The Patent Office under the State Council is responsible for receiving, examining and approving patent applications. A patent is valid for a twenty-year term in the case of an invention and a ten-year term in the case of a utility model or design, starting from the application date. A third-party user must obtain consent or a proper license from the patent owner except for certain specific circumstances provided by law. Otherwise, the use will constitute an infringement of the patent rights.
Patent Law. In general, under the frequently pressure for USA, from the early 1993, China’s new patent law has given the patent protection for pharmaceutical products for 20 years. And the administrative regulation for protecting foreign pharmaceutical products has also came out at that time. It had to be noted that China became a WTO member in 2001 and the TRIPs shall come into force for China at the end of 2002. However China was forced by the US to amend its patent legislations as early as in 1992 and establish the mailbox system to retrospectively protect foreign patents obtained during 1984 and 1993.
Patent Law. Aegis shall promptly supply Opiant with a copy of the disclosure for Opiant evaluation purposes. Opiant shall have the sole right to determine what, if any, patent applications should be filed.
Patent Law. All expenses relating to the preparation, filing, prosecution, extension and maintenance of such jointly-owned patent applications and any patents granted thereon shall be borne by SYNAPTIC. If SYNAPTIC determines:
Patent Law. In the United States, a patent application must be filed no later than one (1) year after first publication disclosing the invention or the software in detail. The term “
Patent Law. Date of application – Myanmar must adopt a law to protect various kinds of IPRs before 1 January 2005 (TRIPS, Art. 66). Currently, only trademark and copyright laws exist in the country. Myanmar is required to adopt the law on patent and industrial design. It must also ensure that geographical indications, layout-design of integrated circuits and undisclosed information are adequately protected in line with relevant provisions in TRIPS. However, since Myanmar is considered a least developed country, it is entitled to delay patent protection for pharmaceutical products until January 1, 2016 as authorised by the Doha Declaration and Public Health (Doha Declaration, para.
